ViiV Healthcare Renews its 2015 Collaboration with UNC-Chapel Hill to Discover a Cure for HIV

ViiV Healthcare Renews their 2015 Collaboration with UNC-Chapel Hill for Five Years


  • ViiV Healthcare has renewed its research agreement with UNC-Chapel Hill to the tune of ~$20M over five years for solely focus on the discovery of therapies for HIV
  • The scientists from both the companies will work at the HIV Cure Center, which was created in 2015 at the start of the collaboration. The public-private collaboration will continue to jointly own Qura Therapeutics, a company managing the IP, commercialization, manufacturing and governance needs of the alliance
  • The partnership is the first-of-its-kind in HIV that brings academic and pharmaceutical research scientists together for developing a new approach to eradicate HIV

Click here ­to­ read full press release/ article | Ref: GSK | Image: Pinterest